Tag: development

New York, NY, July 10, 2025 (GLOBE NEWSWIRE) -- With the rapid development of cryptocurrencies in the past decade, the global financial landscape is undergoing an unprecedented transformation. In this wave, WinnerMining, an innovative smart cloud mining platform in the UK, stands out and is committed to providing global investors with convenient, safe and sustainable digital asset appreciation solutions, especially in terms of stable returns on popular currencies such as BTC、XRP and DOGE.



Simplify the mining process

WinnerMining provides digital currency mining services based on cloud computing power. Users do not need to purchase mining machines or configure power and cooling equipment. They only need to register conveniently through the official website or App to start the mining process with one click. It is easy to get started and there is no threshold to participate.

The platform supports a variety of mainstream currencies, including BTC, ETH, XRP, DOGE, USDT, etc. The contract period covers 1 to 90 days to meet the diversified strategy needs of different investors.

Safe and compliant, trustworthy

In order to ensure the security of user assets, WinnerMining uses McAfee and Cloudflare protection systems and decentralized hosting technology to protect user privacy and asset security. The platform currently covers 180+ countries and regions, and has won a good reputation worldwide. Its compliant operations are transparent and trustworthy.

Highlights of the platform

User-friendly interface: Newbies can quickly get started

Professional trading tools: Provide real-time viewing and contract management

Rich educational resources: Help users to deeply understand the market and strategy

Real-time monitoring system: View income and mining status at any time

24/7 customer support: Multi-language service channels, fast response

Sign up and get $15 computing power reward

New users can get $15 computing power reward for free when they register, and start their exclusive mining experience immediately. Daily income is automatically settled to achieve stable passive income.

Explore the future, join now

At a time when global inflationary pressure continues, the high interest rate cycle is extended, and the volatility of traditional financial markets is intensifying, more and more investors are beginning to seek alternative asset allocation methods with more stability and growth potential. Instead of letting digital assets idle and waiting for a rise, it is better to let them actively "work" to create continuous income. WinnerMining is reshaping the logic of cryptocurrency investment. With the help of green energy-driven intelligent cloud mining technology, it creates a low-threshold, high-efficiency, environmentally friendly and sustainable passive income platform for global users.

Official website: https://winnermining.com

APP download address: Click to download

Disclaimer:

The information contained in this article does not constitute investment advice, financial advice or trading recommendations. Cryptocurrency investment and mining have certain risks and may result in partial or total loss of funds. Users are advised to conduct full due diligence before investing and consult professional financial advisors.

Grants will add 204 units of affordable housing across Flagstaff, Pisinemo and Topawa, Prescott, and Tucson

SANTA ANA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced the administration of the first dose of troculeucel, an expanded autologous NK cell therapy, under a single compassionate use, Investigational New Drug (“IND”) authorization cleared by the U.S. Food and Drug Administration (“FDA”), to a patient with mild-stage Alzheimer’s disease who exhibited continued cognitive decline despite ongoing treatment with lecanemab, an amyloid targeting therapy. This exploratory work is being conducted in collaboration with Anita Fletcher, M.D., a board-certified neurologist with specialized training in neuroimmunology, who also serves as Director of Neuroscience Clinical Research at AdventHealth Neuroscience Institute in Orlando, Florida.

SAN DIEGO, July 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 102,350 shares of its common stock and granted an aggregate of 77,875 restricted stock unit (“RSU”) awards to 46 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).

Kyiv, New York, Dubai, and Philadelphia – July 10, 2025 – VEON Ltd. (Nasdaq: VEON) (“VEON”), a global digital operator, and Cohen Circle Acquisition Corp. I (“Cohen Circle”), a special purpose acquisition company (Nasdaq: CCIR), today announce the execution of non-redemption agreements (“NRAs”) totaling approximately USD 52.3 million with accredited institutional investors, including Helikon and Clearline. These commitments cover approximately 5.05 million CCIR Class A shares, securing the minimum USD 50 million cash condition for the proposed business combination of Kyivstar Group Ltd (“Kyivstar Group”) and Cohen Circle (the “Business Combination”).

HUNTSVILLE, AL, July 10, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced Parkinson's disease, enabled by its proprietary POZ Platform^™ drug optimization technology, announced that it has made a grant of options to purchase an aggregate of 12,500 shares of Serina’s common stock to a new non-executive employee on June 18, 2025 (the “Option Grant”).

HHH to Host Earnings Call at 10 AM ET on August 7, 2025